This study is in progress, not accepting new patients

An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

a study on Uterine Fibroids Arteriovenous Malformation Hypervascular Tumors Benign Prostatic Hyperplasia

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCLA
Dates
study started
estimated completion

Description

Summary

This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.

Official Title

The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

Keywords

Uterine Fibroid, Arteriovenous Malformations, Hypervascular Tumors, Benign Prostatic Hyperplasia, Leiomyoma, Prostatic Hyperplasia, Hyperplasia, Treatment with HydroPearl via radial access

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Subject is ≥ 18 years old
  2. Subject is scheduled for a procedure for treatment with HydroPearl microspheres using radial access.
  3. Subject is willing and able to complete follow-up requirements
  4. Subject is willing and able to sign a written Informed Consent form prior to participating in the registry.

You CAN'T join if...

  1. Unable to have a procedure with radial access for any reason.
  2. Participating in another clinical study which, in the opinion of the investigator, could impact the results of this registry.
  3. Pregnant or planning to become pregnant during the study.

Locations

  • University of California - Los Angeles
    Los Angeles California 90095 United States
  • SLU Department of Radiology
    Saint Louis Missouri 63110 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Terumo Medical Corporation
ID
NCT04272216
Study Type
Observational [Patient Registry]
Participants
About 99 people participating
Last Updated